XTX Topco’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.44M Buy
63,689
+17,510
+38% +$1.81M 0.08% 268
2026
Q1
$4.47M Buy
46,179
+15,467
+50% +$1.59M 0.08% 341
2025
Q4
$3.26M Buy
30,712
+26,425
+616% +$3.06M 0.09% 283
2025
Q3
$545K Sell
4,287
-25,316
-86% -$3.01M 0.03% 1005
2025
Q2
$3.63M Buy
29,603
+27,471
+1,289% +$3.14M 0.15% 131
2025
Q1
$216K Sell
2,132
-3,874
-65% -$378K 0.01% 1651
2024
Q4
$555K Sell
6,006
-13,187
-69% -$1.29M 0.05% 687
2024
Q3
$1.85M Buy
19,193
+9,191
+92% +$826K 0.13% 168
2024
Q2
$858K Buy
+10,002
New +$839K 0.07% 416
2023
Q3
Sell
-4,469
Closed -$303K 1672
2023
Q2
$303K Buy
+4,469
New +$280K 0.05% 714
2022
Q3
Sell
-5,308
Closed -$237K 1162
2022
Q2
$237K Buy
+5,308
New +$272K 0.1% 387

Other funds holding EHC

XTX Topco's EHC Position: Q2 2026 in Review

XTX Topco increased its Encompass Health (EHC) stake by 38% in Q2 2026, buying an estimated $1.81M and bringing the position to 63,689 shares worth $6.44M. The position accounts for 0.08% of the portfolio, ranked #268.

XTX Topco first reported a position in EHC in Q2 2022 and has held it in 11 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • XTX Topco held 63,689 shares of Encompass Health worth $6.44M as of Q2 2026.
  • XTX Topco bought 17,510 Encompass Health shares in Q2 2026, an estimated $1.81M.
  • Encompass Health made up 0.08% of XTX Topco's portfolio in Q2 2026, its #268 holding.
  • XTX Topco first reported a position in Encompass Health in Q2 2022 and has held it in 11 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.